NCT05679206View on ClinicalTrials.gov

Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure

RecruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

December 20, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Pre-Eclampsia; Complicating PregnancyAntiphospholipid Syndrome in PregnancyPulmonary Hypertension
Interventions
DIAGNOSTIC_TEST

Echocardiography images

"Transthoracic echocardiographic (Vivid E95) performed in all included patients between three months and three years after delivery.~* Left ventricular ejection fraction,~* Left ventricular mass index,~* Septal and lateral mitral annular E-wave velocity assessed by tissue Doppler,~* Tricuspid annular plane systolic excursion,~* Left atrial volume index,~* Right ventricle to right atrium (RV/RA) gradient"

DIAGNOSTIC_TEST

24-hour ambulatory blood pressure monitoring

Twenty-four-hour ABPM performed between three months and three years after delivery using validated recorders (Spacelabs model 90217, USA)

Trial Locations (1)

3010

RECRUITING

Inselspital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER